
    
      To determine plasma levels of VEGF and serum Pharmacokinetic (PK) levels after varying
      lengths of time following intravitreal injection with Avastin, Lucentis, or Eylea in
      exudative macular degeneration. Patients will be tested while following a normal course of
      treatment in our institute. All screenings and testing will be conducted in three study
      visits.
    
  